1 year return (CAGR)
34.55%
Achilles Therapeutics PLC ADR Exchange (NASDAQ, USD)
ACHL
-
+0.01 (+0.68%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-20.81%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
60.83M
Price/Sales
-
Ent value
-5.69M
Price/Book
0.59
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 1.48 |
| Daily high | 1.50 |
| Daily low | 1.45 |
| Daily Volume | 1.20M |
| 1y analyst estimate | 0.50 |
| Beta | 1.25 |
| EPS (TTM) | -1.65 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ACHL | S&P500 | |
| Current price drop from All-time high | -91.71% | -7.74% |
| Highest price drop | -96.08% | -56.47% |
| Date of highest drop | 11 Sep 2024 | 9 Mar 2009 |
| Avg drop from high | -83.78% | -10.68% |
| Avg time to new high | 333 days | 12 days |
| Max time to new high | 995 days | 1805 days |
News
No items found